More SEC Filings
View Older Stories View Newer Stories-
Form 4 Five9, Inc. For: Sep 04 Filed by: Dignan Andy
-
Form 4 Falcon's Beyond Global, For: Sep 05 Filed by: Whittaker Yvette
-
Form 4 Five9, Inc. For: Sep 04 Filed by: Lee Bryan M
-
Form 4 LEMAITRE VASCULAR INC For: Sep 04 Filed by: LeBlanc Dorian Paul
-
Form 4 Crexendo, Inc. For: Sep 04 Filed by: Gaylor Douglas Walter
-
Form 4 LEMAITRE VASCULAR INC For: Sep 04 Filed by: Pellegrino Joseph P JR
-
Form 4 Beta Bionics, Inc. For: Sep 04 Filed by: Hopman Mark
-
Form 4 Beta Bionics, Inc. For: Sep 05 Filed by: Feider Stephen
-
Form 4 Five9, Inc. For: Sep 04 Filed by: Mansharamani Leena
-
Form 4 LEMAITRE VASCULAR INC For: Sep 04 Filed by: Roberts David B
-
Form 4 BWX Technologies, Inc. For: Sep 05 Filed by: Melvin Leland D
-
Form 4 Rackspace Technology, For: Sep 08 Filed by: Scott Anthony
-
Form 4 Rackspace Technology, For: Sep 04 Filed by: Kandiah Gajakarnan Vibushanan
-
Form 4 BWX Technologies, Inc. For: Sep 05 Filed by: JASKA JAMES M
-
Form 3 Rackspace Technology, For: Sep 03 Filed by: Kandiah Gajakarnan Vibushanan
-
Form 4 Five9, Inc. For: Sep 04 Filed by: Burkland Michael
-
Form 4 BWX Technologies, Inc. For: Sep 05 Filed by: Krieg Kenneth J
-
Form 4 Academy Sports & Outdoor For: Sep 06 Filed by: Ford Earl Carlton IV
-
Form 4 PennyMac Financial Servi For: Sep 05 Filed by: Perotti Daniel Stanley
-
Form 4 BridgeBio Pharma, Inc. For: Sep 05 Filed by: MCCORMICK FRANK
-
Form 4 FENNEC PHARMACEUTICALS For: Sep 05 Filed by: Raykov Rosty
-
Form 4 BridgeBio Pharma, Inc. For: Sep 04 Filed by: Kumar Neil
-
Form 4 Academy Sports & Outdoor For: Sep 06 Filed by: McCabe Matthew M.
-
Form 4 Dream Finders Homes, For: Sep 04 Filed by: Lovett William Radford II
-
Form 4 Stagwell Inc For: Sep 04 Filed by: Gross Bradley J.
-
Form 4 Affirm Holdings, Inc. For: Sep 04 Filed by: Jiyane Siphelele
-
Form 3 ENANTA PHARMACEUTICALS For: Aug 26 Filed by: Capps Kathleen S.
-
Form 3 ENANTA PHARMACEUTICALS For: Aug 26 Filed by: Trout Harry R. III
-
Form SCHEDULE 13D/A Mineralys Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SCHEDULE 13G vTv Therapeutics Inc. Filed by: Trails Edge Capital Partners, LP
-
Form 4 Mineralys Therapeutics, For: Sep 04 Filed by: Shah Rajeev M.
-
Form 4 KINDER MORGAN, INC. For: Sep 08 Filed by: Schlosser John W
-
Form 4 Five9, Inc. For: Sep 04 Filed by: Meriweather Tiffany N.
-
Form 4 Hamilton Insurance Group For: Sep 05 Filed by: Bernhard Keith Donald
-
Form 4 Axos Financial, Inc. For: Sep 05 Filed by: Garrabrants Gregory
-
Form 4 ACI WORLDWIDE, INC. For: Sep 04 Filed by: Litch Erich J
-
Form 144 Warby Parker Inc. Filed by: Cutler Joel E
-
Form 4 Dolphin Entertainment, For: Sep 08 Filed by: O'Dowd William IV
-
Form SCHEDULE 13D Armada Acquisition Corp. Filed by: Arrington XRP Capital Fund, LP
-
Form 4 Dynatrace, Inc. For: Sep 04 Filed by: Campbell Lisa M
-
Form 144/A HUBSPOT INC Filed by: Shah Dharmesh
-
Form 4 Perimeter Solutions, For: Sep 05 Filed by: Sable Kyle
-
Form 4 Perimeter Solutions, For: Sep 04 Filed by: Emery Jeffrey
-
Form 4 Fabrinet For: Sep 05 Filed by: Knight Darlene S.
-
Form 4 Fabrinet For: Sep 05 Filed by: KELLY THOMAS F
-
Form 4 GT Biopharma, Inc. For: Sep 04 Filed by: Mun-Gavin David C.
-
Form 4 GT Biopharma, Inc. For: Sep 04 Filed by: Breen Michael Martin
-
Form 4 GT Biopharma, Inc. For: Sep 04 Filed by: CASAMENTO CHARLES J
-
Form 4 GT Biopharma, Inc. For: Sep 04 Filed by: URBAN ALAN LOUIS
-
Form 4 GT Biopharma, Inc. For: Sep 04 Filed by: Kramer Hilary
